Neal Gilmer of Haywood Securities reiterated a “Buy” rating and $1.00 price target on Ascend Wellness Holdings (Ascend Wellness Holdings Stock Quote, Chart, News, Analysts, Financials CSE:AAWH.U) after the company reported fourth-quarter results that matched its earlier pre-announcement. Ascend Wellness is a U.S. cannabis company that grows and sells both medical and recreational products. It […]
Roth Capital Partners analyst Adam Walsh initiated coverage of Equillium (Equillium Stock Quote, Chart, News, Analysts, Financials NASDAQ:EQ) with a “Buy” rating and US$12.00 price target, citing the potential of the company’s lead program targeting ulcerative colitis. Equillium is a biotechnology company developing therapies for severe autoimmune and inflammatory diseases. Walsh said the firm’s lead […]
Share
Tweet
Share
